my thinking does include costs. so you'd have to be close in your estimation. when we look at our Elma Generic, the CEO has stated that some months Perrigo has achieved some 50% of total US sales from a $US36-39m seller. Then look at the stated revenue in the accounts, which is difficult as they don't separate/list the earning of each individual drug. Its all lumped together. Jet/
my thinking does include costs. so you'd have to be close in...
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 434 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 17258 | 1 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable